Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Microbiol 80 , 29912997 (2014)
Common peptide-specific adverse events to monitor include: Proper Blinding and Randomization Peptide research is particularly susceptible to observer bias because many endpoints (wound healing scores, behavioral assessments, food intake measurements) require subjective judgment: Allocation concealment: Have a colleague not involved in endpoint assessment prepare and label dosing solutions with codes only (no peptide names or doses visible) Blinding levels: Single-blind: The person administering treatments knows the identity, but the person assessing endpoints does not Double-blind: Both administering and assessing personnel are blinded
Prud'homme GJ, Kurt M, Wang Q
SCHEME 4 SCHEME 5 4 PDE10 PDE10 is a dual-substrate hydrolase that acts on cAMP and cGMP
Robins says she no longer offers BPC-157 and other peptides that have been targeted by the FDA
US$ 24.04
US$ 20.96
US$ 22.62
US$ 20.76
US$ 29.16
US$ 22.56
